FindTrial
Sign In

comparison between two regional blocks to decrease the post operative pain in patients undergoing total knee replacement

Comparative study between Vastus intermedius and sartorius(VISA)plane block with IPACK and classical mid adductor canal block using 0.2% ropivacaine in case of total knee replacement - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080821
Enrollment
40
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Vastus intermedius sartorius plane block(VISA): Patients will be receiving 10 mL of 0.2% ropivacaine in vastus intermedius and sartorius plane. Control Intervention1: Adductor canal blo

Sponsors

institute of medical sciences, bhu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA 1) Patients with 40-80 years 2) Patients undergoing unilateral Total knee replacement 3) ASA I, II & III

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA 1) Patients refusal for participating in the study 2) Injection site infection or sepsis 3) Coagulopathy or other bleeding diathesis 4) Hepatic or renal failure

Design outcomes

Primary

MeasureTime frame
Assessment of post-operative pain using NRS scale at active knee flexion at 12 hours post total knee replacementTimepoint: Upto 12 hours—

Secondary

MeasureTime frame
numerical rating scaleTimepoint: 4 hour,8hour,12 hour,24 hour,36 hour,48 hour,;Quadriceps strength testTimepoint: 8 hour,12 hour,24 hour,36 hour,48 hour;Duration of blockTimepoint: when patient complained of pain;Quality of recovery using 15 questionnaireTimepoint: at 48 hours;Number of time the rescue analgesic was usedTimepoint: at 48 hours—

Countries

India

Contacts

Public ContactDr Amrita rath

institute of medical sciences

amritar@bhu.ac.in7379140545

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026